Is oral rapamycin useful in preventing coronary stent restenosis? A randomized study

被引:0
|
作者
Sarmiento, Ricardo A.
Cherro, Alejandro
Szarfer, Jorge L.
Lynch, Angeles Videla
Solerno, Raul
Grinfeld, Diego
Ferrari, Pablo
Campo, Anibal
机构
[1] Hosp Frances Riosa, Buenos Aires, DF, Argentina
[2] Hosp Argerich, Buenos Aires, DF, Argentina
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2006年 / 98卷 / 8A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:198M / 198M
页数:1
相关论文
共 50 条
  • [21] Is there a role for oral rapamycin in restenosis prevention after bare-metal stent implantation?
    Hausleiter, Joerg
    Kastrati, Adnan
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (09): : 476 - 477
  • [22] Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS study)
    Mudra, H
    di Mario, C
    de Jaegere, P
    Figulla, HR
    Macaya, C
    Zahn, R
    Wennerblom, B
    Rutsch, W
    Voudris, V
    Regar, E
    Henneke, KH
    Schächinger, V
    Zeiher, A
    CIRCULATION, 2001, 104 (12) : 1343 - 1349
  • [23] Randomized study of sirolimus-eluting stent implantation versus coronary brachytherapy for diffuse in-stent restenosis
    Park, SJ
    Kim, YH
    Kim, MJ
    Ko, KH
    Park, KM
    Lee, CW
    Hong, MK
    Kim, JJ
    Lee, MM
    Koo, BK
    Park, SW
    CIRCULATION, 2004, 110 (17) : 564 - 564
  • [24] A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis
    Colombo, Antonio
    Basavarajaiah, Sandeep
    Limbruno, Ugo
    Picchi, Andrea
    Lettieri, Corrado
    Valgimigli, Marco
    Sciahbasi, Alessandro
    Prati, Francesco
    Calabresi, Marco
    Pierucci, Daniela
    Guglielmotti, Angelo
    EUROINTERVENTION, 2016, 12 (11) : E1385 - E1394
  • [25] Preventing Restenosis after Implantation of Bare Stents with Oral Rapamycin: A Randomized Angiographic and Intravascular Ultrasound Study with a 5-Year Clinical Follow-Up
    Cernigliaro, Carmelo
    Sansa, Mara
    Vitrella, Giancarlo
    Verde, Alessandro
    Bongo, Angelo Sante
    Giuliani, Luigi
    Novelli, Eugenio
    CARDIOLOGY, 2010, 115 (01) : 77 - 86
  • [26] Preventing coronary restenosis and complications
    Holmes, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (24): : 1748 - 1749
  • [27] Assessment of side effects of 2 different therapeutic regimes of oral rapamycin for stent restenosis prevention
    Costantini, CR
    Zanuttini, D
    Tarbine, S
    Darwich, R
    Freitas, M
    Costantini, CO
    Maranhao, M
    Andrade, M
    Lazarte, JL
    Oliveira, MR
    Sabattini, L
    Yared, G
    Bubna, M
    Moraes, AS
    Garcia, O
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 184L - 185L
  • [28] Inflamation and restenosis in coronary stent
    Calinescu, Blanca
    Cirstea, Adela
    Kibos Samwel, Ambrose
    Nita, Daniel
    Cristian, Gabriel
    Pinte, Florina
    Dumitrescu, Silviu
    Chiriac, Liviu
    Greere, Vasile
    Grama, Lavinia
    Tintoiu, Ion
    ROMANIAN JOURNAL OF MILITARY MEDICINE, 2011, 114 (03) : 11 - 23
  • [29] CORONARY ANGIOPLASTY FOR STENT RESTENOSIS
    ONEILL, WW
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (02): : 132 - 132
  • [30] THE ANTI-RESTENOSIS EFFECTS OF RAPAMYCIN AND PACLITAXEL ELUTING STENT IN SUSSCROTA DOMESTICA CORONARY ARTERY
    Kong, Hong-liang
    Kong, Hong-liang
    HEART, 2012, 98 : E53 - E53